Clinical Trial Details
| Trial ID: | L5128 |
| Source ID: | NCT05611684 |
| Associated Drug: | Polyethylene Glycol Losenatide |
| Title: | The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients |
| Acronym: | |
| Status: | RECRUITING |
| Study Results: | NO |
| Results: | |
| Conditions: | Type2 Diabetes Mellitus |
| Interventions: | DRUG: Polyethylene Glycol Losenatide |
| Outcome Measures: | Primary: blood sugar changes, Effects of polyethylene glycol Losenatide on blood sugar changes in Patients With Type 2 Diabetes Mellitus., 12 weeks|blood lipid changes, Efficacy of polyethylene glycol Losenatide on blood lipid changes in patients with type 2 diabetes, 12 weeks | Secondary: Body composition analysis, Efficacy of polyethylene glycol Losenatide on body composition changes in patients with type 2 diabetes, 12 weeks|Inflammation factors, Effects of polyethylene glycol Losenatide on inflammation factors in Patients With Type 2 Diabetes Mellitus,after being intervened for 12 weeks,changes of Inflammation factors were observed, including adiponectin,leptin,IL-1,IL-6,IL-18,TNF-α,ghrelin,asprosin., 12 weeks |
| Sponsor/Collaborators: | Sponsor: Nanjing First Hospital, Nanjing Medical University |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 480 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2022-06-01 |
| Completion Date: | 2025-12-31 |
| Results First Posted: | |
| Last Update Posted: | 2022-11-10 |
| Locations: | Jianhua Ma, Nanjing, Jiangsu, 210006, China |
| URL: | https://clinicaltrials.gov/show/NCT05611684 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|